Home
Neurelis

Neurelis Market Share Analysis for February 2026

Sign up to receive the latest news from Neurelis and stay up-to-date on all news, events, and pipeline information about the pharmaceutical company.

Industry: N/A

Domainneurelis.com

Year Founded2007

Employees51 - 200

Annual Revenue$2M - $5M

Neurelis

Neurelis (including company regionals)

neurelis.com

See more website traffic and engagement information

Neurelis Revenue up to February 2026 is 2M - 5M

revenue generated by Neurelis top domains

Neurelis top domains revenue over 3 years

Revenue for Neurelis top domains

neurelis.com2M - 5M

See more with Sales Intelligence

Total visits to Neurelis's top domains

Understand Neurelis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

neurelis.com3.4K

See more with Sales Intelligence

Avg. visit duration in Neurelis's top domains

Analyze Neurelis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

neurelis.com00:00:16

See more with Sales Intelligence

Avg. pageviews on Neurelis's top domains

See how Neurelis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

neurelis.com1.55

See more with Sales Intelligence

Neurelis top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Neurelis

These are the website technologies, by industry, used by Neurelis top domains

Content Management System (6)

WordPress

Widget (5)

Twemoji

Advertising (4)

DoubleClick

Marketing (3)

Google Marketing Platform

More Technologies

11

See all

News & Signals from Neurelis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeurelis, Inc. attends event 13th Annual Sofie's Journey Epilepsy Awareness Day & Education Expo.San Diego, CA - November 10, 2025 - Neurelis, Inc., the innovator behind VALTOCO(R)(diazepam nasal spray), today announced it will join the epilepsy community at the 13th Annual Sofie's Journey Epilepsy Awareness Day & Education Expo at Disneyland (EADDL), one of the largest gatherings of people with epilepsy, care partners, and healthcare practitioners.

NewsNeurelis, Inc. attends event 76th Annual Meeting.Neurelis announces two poster presentations at the 76th Annual Meeting of the American Academy of Neurology.

NewsNeurelis, Inc. promoted Adrian L. Rabinowicz to Chief Medical Officer on May 15th '23.SAN DIEGO, CA - May 15, 2023 - Neurelis, Inc., announced today the promotion of Adrian L. Rabinowicz, MD, to Chief Medical Officer and the establishment of a new leadership position of Senior Vice President, Strategic Initiatives for Enrique Carrazana, MD.